Response to Pazopanib in Two Pediatric Patients with Pretreated Relapsing Synovial Sarcoma

Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group

(2016) Monika Scheer et al.   PEDIATRIC BLOOD & CANCER

Age as an independent prognostic factor for survival of localised synovial sarcoma patients

(2015) Myrella Vlenterie et al.   BRITISH JOURNAL OF CANCER

Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)

(2014) A. Ferrari et al.   ANNALS OF ONCOLOGY

Chromosome Instability Accounts for Reverse Metastatic Outcomes of Pediatric and Adult Synovial Sarcomas

(2013) Pauline Lagarde et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

(2013) Julia L. Glade Bender et al.   JOURNAL OF CLINICAL ONCOLOGY

Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma

(2012) Andrea Ferrari et al.   EUROPEAN JOURNAL OF CANCER

Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005

(2009) Iyad Sultan et al.   CANCER

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

(2009) Stefan Sleijfer et al.   JOURNAL OF CLINICAL ONCOLOGY

Synovial sarcoma of children and adolescents: The prognostic role of axial sites

(2008) Andrea Ferrari et al.   EUROPEAN JOURNAL OF CANCER